Haloperidol removed, ondansetron replaced, citalopram reduced and donepezil kept with ECG checks: this NU648 QT risk review works through one composite older woman's orders. Searches like "nu 648 unit 7 assignment example", "nu648 unit 7 sample" and "nu648 unit 7 example" land here.
What a finished NU648 Unit 7 QT risk review looks like
Across three pages, a risk section first applies the Tisdale score (Circulation: Cardiovascular Quality and Outcomes, 2013), awarding points for age, female sex, loop diuretic use, potassium of [3.3] mEq/L, a baseline QTc above [450] ms, heart failure and two or more QT-prolonging drugs, for a total of [13], high risk. A medication table lists each agent with its CredibleMeds category, indication and decision. As-needed haloperidol for nighttime agitation is discontinued in favor of delirium prevention measures. Ondansetron gives way to treating the constipation behind her nausea. Citalopram drops to the [20] mg ceiling the FDA set for patients over [60]. Donepezil continues with repeat ECGs. A correction paragraph targets potassium and magnesium. Throughout, the review cites the 2010 AHA/ACCF scientific statement on preventing torsade de pointes in hospital settings.
How a NU648 Unit 7 example is structured
Scoring comes before any drug decision, so the review knows how much risk it is managing before choosing what to change. The Tisdale total places her in the high-risk band, which justifies acting on several agents at once rather than one. Each drug is then judged on three questions in order: is it needed, is there a lower-risk alternative for the same purpose, and if it must continue, what monitoring makes that acceptable. That order explains why the four agents receive four different outcomes. Haloperidol fails the first question, since nighttime agitation has non-drug options; ondansetron fails the second; citalopram passes both but exceeds the age-adjusted dose; donepezil passes all three, because stopping it would cost her cognition. Modifiable contributors, potassium, magnesium and the loop diuretic, get their own paragraph. A monitoring plan with a QTc threshold for action closes the review.
Risk scored before decisions
Seven Tisdale items give a total of [13], above the high-risk threshold of [11]. Each point is shown with its source in the chart, letting a reader audit the total rather than trust it.
Is it needed at all
As-needed haloperidol for nighttime agitation is stopped. Glasses and hearing aids within reach, a visible clock and protected sleep come first, and the review notes the boxed warning antipsychotics carry for older adults with dementia.
Is there a safer substitute
Ondansetron goes because her nausea traces to constipation from reduced mobility. Treating the cause removes the need for any antiemetic, the review argues, which beats trading one QT-prolonging agent for another.
Can the dose come down
Citalopram at [40] mg exceeds the ceiling the FDA set for patients over [60]. The review reduces it to [20] mg and records the original prescriber, the indication and a plan to reassess mood.
Keep it, and watch
Donepezil stays, since stopping it may worsen cognition. A repeat ECG after electrolyte correction and a QTc of [500] ms as the threshold for review make continuation defensible.
Where marks go in NU648 Unit 7
A review that lists the QT-prolonging drugs without scoring the patient gives markers no basis for judging how aggressive to be, and it is marked as incomplete. Stopping every agent at once looks as unreasoned as stopping none, since distinctions are the point of the unit. Replacing ondansetron with another antiemetic that also lengthens the QT interval is a frequent trap and draws a correction. Electrolytes left uncorrected, especially alongside a loop diuretic, miss the easiest modifiable risk. Bazett's correction applied without comment at a fast heart rate overstates the interval and costs accuracy. Monitoring without a threshold for action reads as a promise rather than a plan. CredibleMeds categories cited without the date accessed lose a little, since those lists change.
Get a NU648 Unit 7 example written to your instructions
Pass along the NU648 Unit 7 medication list with the ECG values, electrolytes and rubric. At no cost as a first order and typically ready within 24-48h, the sample scores the patient's risk before touching any drug, then gives each QT-prolonging agent its own reasoned outcome, with monitoring and a threshold for action.
NU648 Unit 7 questions, answered
Should the review use Bazett or Fridericia?
Fridericia is generally preferred when the heart rate is fast or slow, because Bazett overcorrects at higher rates and can make a normal interval look prolonged. Many ECG machines report Bazett by default. The sample names the correction used, gives the reason, and recalculates if the case supplies only one version.
Is CredibleMeds an acceptable source?
Yes, and it is widely used for classifying QT risk. Because its lists are updated, the sample cites the category with the date it was checked. For decisions about a specific drug, the product label and primary studies can support the classification, and the sample adds them where the argument depends on magnitude.
Does every high-risk patient need telemetry?
Not necessarily. The AHA/ACCF statement describes indications for QT monitoring in hospital settings, and they depend on the drugs, the baseline interval and the clinical setting. The sample describes the monitoring its composite patient would warrant, with the source, and leaves actual monitoring orders to the clinicians responsible for her care.